Search results
Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says
CNN via Yahoo News· 8 months agoin a Phase 1/2 clinical trial, Moderna’s combination vaccine appeared to elicit “strong” immune...
Moderna Crumbles As Cancer Vaccine Data Show A 'Longish And Complex' Road
Investor's Business Daily· 1 year agoModerna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine showed a...
Moderna Surges After Flu Shot Beats Out Widely Used Sanofi, GSK Vaccines
Investor's Business Daily· 9 months agoModerna stock popped Wednesday after the company said its experimental flu shot outperformed broadly...
Moderna (MRNA) Up on Upbeat Data From Phase III Study on RSV Jab
Zacks via Yahoo Finance· 1 year agoData from a late-stage study showed that Moderna's (MRNA) RSV vaccine was 83.7% effective at...
Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab Setback
Zacks via Yahoo Finance· 1 year agoModerna (MRNA) expects $8-$15 billion in product revenues from the respiratory vaccine by 2027. Its...
Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoModerna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript May 4, 2023 Operator: Good day and...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 1 month agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 6 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoModerna (NASDAQ: MRNA) jumped into the limelight when it started developing a coronavirus vaccine candidate. And the stock soared as the vaccine raced...
Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine
Investor's Business Daily· 6 months agoModerna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma...